F Lurie Medical is categorized under Operators of Nonresidential Buildings in Delray Beach, FL and active since 2001.
F Lurie Medical was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Operators of Nonresidential Buildings business, which does work in the B2B market, and is classified as a Operators of Nonresidential Buildings, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Fayva Lurie at the company’s single location by writing to 5162 Linton Boulevard # 103, Delray Beach, Florida FL 33484 or by phoning (561) 637-5780. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | F Lurie Medical |
| Contact Person: | Fayva Lurie |
| Address: | 5162 Linton Boulevard # 103, Delray Beach, Florida 33484 |
| Phone Number: | (561) 637-5780 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Operators of Nonresidential Buildings |
| SIC Code: | 6512 |
| NAICS Code: | 6211110 |
| Share This Business: |
F Lurie Medical was started in 2001 to provide professional Operators of Nonresidential Buildings under the SIC code 6512 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Fayva Lurie for inquiries that concern F Lurie Medical by calling the company number (561) 637-5780, as your correspondence is most welcome. Additionally, the physical location of the single location of F Lurie Medical can be found at the coordinates 26.4392,-80.12577 as well as the street address 5162 Linton Boulevard # 103 in Delray Beach, Florida 33484.
For its online presence, you may visit F Lurie Medical’s website at and engage with its social media outlets through on Twitter and on Facebook.